OTC:LGNZZ | Insider Transactions — Page 6 | LIGAND PHARMACEUTICALS INC

LGNZZ Insider Transactions — Page 6

1,727 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–600; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Sharp John PVP Finance and CFO2014-02-12Sale6,086.0$74.27
Sharp John PVP Finance and CFO2014-02-12Sale6,012.0$75.73
Sharp John PVP Finance and CFO2014-02-12Sale7,321.0$74.27
Sharp John PVP Finance and CFO2014-02-12Sale8,333.0$75.73
Sharp John PVP Finance and CFO2014-02-12Sale1,000.0$74.27
Sharp John PVP Finance and CFO2014-02-12Sale16,666.0$74.27
Sharp John PVP Finance and CFO2014-02-12Sale1,166.0$74.27
Berkman Charles SVP, Gen. Counsel & Secretary2014-02-12Sale1,736.0$74.5
Berkman Charles SVP, Gen. Counsel & Secretary2014-02-12Sale1,230.0$74.5
Berkman Charles SVP, Gen. Counsel & Secretary2014-02-12Sale4,779.0$74.5
Berkman Charles SVP, Gen. Counsel & Secretary2014-02-12Sale4,584.0$74.5
Berkman Charles SVP, Gen. Counsel & Secretary2014-02-12Sale1,000.0$74.5
Berkman Charles SVP, Gen. Counsel & Secretary2014-02-12Sale1,166.0$74.5
Berkman Charles SVP, Gen. Counsel & Secretary2014-02-12Sale386.0$74.5
HIGGINS JOHN LPresident & CEO2014-02-12Sale16,875.0$75.0
HIGGINS JOHN LPresident & CEO2014-01-16Sale15,000.0$64.0
FOEHR MATTHEW WEVP and COO2013-12-31Purchase84.0$33.92
Berkman Charles SVP, Gen. Counsel & Secretary2013-12-31Purchase209.0$33.92
Sharp John PVP Finance and CFO2013-12-12Sale700.0$53.44
FOEHR MATTHEW WEVP and COO2013-12-12Sale6,000.0$53.4
Sharp John PVP Finance and CFO2013-12-06Sale6,000.0$56.08
BIOTECHNOLOGY VALUE FUND L POther2013-11-27Sale154,578.0$57.07
BVF PARTNERS L P/ILTenPercentOwner2013-11-27Sale154,578.0$57.07
BVF INC/ILTenPercentOwner2013-11-27Sale154,578.0$57.07
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-27Sale154,578.0$57.07
BVF INVESTMENTS LLCOther2013-11-27Sale154,578.0$57.07
INVESTMENT 10 LLCOther2013-11-27Sale154,578.0$57.07
LAMPERT MARK NTenPercentOwner2013-11-27Sale154,578.0$57.07
BIOTECHNOLOGY VALUE FUND L POther2013-11-27Sale27,058.0$57.07
BVF PARTNERS L P/ILTenPercentOwner2013-11-27Sale27,058.0$57.07
BVF INC/ILTenPercentOwner2013-11-27Sale27,058.0$57.07
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-27Sale27,058.0$57.07
BVF INVESTMENTS LLCOther2013-11-27Sale27,058.0$57.07
INVESTMENT 10 LLCOther2013-11-27Sale27,058.0$57.07
LAMPERT MARK NTenPercentOwner2013-11-27Sale27,058.0$57.07
BIOTECHNOLOGY VALUE FUND L POther2013-11-27Sale50,934.0$57.07
BVF PARTNERS L P/ILTenPercentOwner2013-11-27Sale50,934.0$57.07
BVF INC/ILTenPercentOwner2013-11-27Sale50,934.0$57.07
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-27Sale50,934.0$57.07
BVF INVESTMENTS LLCOther2013-11-27Sale50,934.0$57.07
INVESTMENT 10 LLCOther2013-11-27Sale50,934.0$57.07
LAMPERT MARK NTenPercentOwner2013-11-27Sale50,934.0$57.07
BIOTECHNOLOGY VALUE FUND L POther2013-11-27Sale86,435.0$57.07
BVF PARTNERS L P/ILTenPercentOwner2013-11-27Sale86,435.0$57.07
BVF INC/ILTenPercentOwner2013-11-27Sale86,435.0$57.07
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-27Sale86,435.0$57.07
BVF INVESTMENTS LLCOther2013-11-27Sale86,435.0$57.07
INVESTMENT 10 LLCOther2013-11-27Sale86,435.0$57.07
LAMPERT MARK NTenPercentOwner2013-11-27Sale86,435.0$57.07
BIOTECHNOLOGY VALUE FUND L POther2013-11-26Sale34,917.0$57.57
BVF PARTNERS L P/ILTenPercentOwner2013-11-26Sale34,917.0$57.57
BVF INC/ILTenPercentOwner2013-11-26Sale34,917.0$57.57
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-26Sale34,917.0$57.57
BVF INVESTMENTS LLCOther2013-11-26Sale34,917.0$57.57
INVESTMENT 10 LLCOther2013-11-26Sale34,917.0$57.57
LAMPERT MARK NTenPercentOwner2013-11-26Sale34,917.0$57.57
BIOTECHNOLOGY VALUE FUND L POther2013-11-26Sale54,444.0$57.57
BVF PARTNERS L P/ILTenPercentOwner2013-11-26Sale54,444.0$57.57
BVF INC/ILTenPercentOwner2013-11-26Sale54,444.0$57.57
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-26Sale54,444.0$57.57
BVF INVESTMENTS LLCOther2013-11-26Sale54,444.0$57.57
INVESTMENT 10 LLCOther2013-11-26Sale54,444.0$57.57
LAMPERT MARK NTenPercentOwner2013-11-26Sale54,444.0$57.57
BIOTECHNOLOGY VALUE FUND L POther2013-11-26Sale119,139.0$57.57
BVF PARTNERS L P/ILTenPercentOwner2013-11-26Sale119,139.0$57.57
BVF INC/ILTenPercentOwner2013-11-26Sale119,139.0$57.57
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-26Sale119,139.0$57.57
BVF INVESTMENTS LLCOther2013-11-26Sale119,139.0$57.57
INVESTMENT 10 LLCOther2013-11-26Sale119,139.0$57.57
LAMPERT MARK NTenPercentOwner2013-11-26Sale119,139.0$57.57
Sharp John PVP Finance and CFO2013-11-18Sale1,123.0$53.0
HIGGINS JOHN LPresident & CEO2013-10-18Sale10,000.0$55.0
BIOTECHNOLOGY VALUE FUND L POther2013-09-23Sale147,806.0$44.5
BVF PARTNERS L P/ILTenPercentOwner2013-09-23Sale147,806.0$44.5
BVF INC/ILTenPercentOwner2013-09-23Sale147,806.0$44.5
BIOTECHNOLOGY VALUE FUND II LPOther2013-09-23Sale147,806.0$44.5
BVF INVESTMENTS LLCOther2013-09-23Sale147,806.0$44.5
LAMPERT MARK NTenPercentOwner2013-09-23Sale147,806.0$44.5
BIOTECHNOLOGY VALUE FUND L POther2013-09-23Sale211,217.0$44.5
BVF PARTNERS L P/ILTenPercentOwner2013-09-23Sale211,217.0$44.5
BVF INC/ILTenPercentOwner2013-09-23Sale211,217.0$44.5
BIOTECHNOLOGY VALUE FUND II LPOther2013-09-23Sale211,217.0$44.5
BVF INVESTMENTS LLCOther2013-09-23Sale211,217.0$44.5
LAMPERT MARK NTenPercentOwner2013-09-23Sale211,217.0$44.5
KNOTT DAVID MDirector2013-09-12Sale160,000.0$46.78
Berkman Charles SVP, Gen. Counsel & Secretary2013-08-30Sale7,020.0$47.54
Berkman Charles SVP, Gen. Counsel & Secretary2013-08-30Sale11,804.0$47.54
Berkman Charles SVP, Gen. Counsel & Secretary2013-08-30Sale9,499.0$47.54
Sharp John PVP Finance and CFO2013-08-16Sale7,500.0$42.75
Berkman Charles SVP, Gen. Counsel & Secretary2013-08-16Sale14,583.0$42.63
HIGGINS JOHN LPresident & CEO2013-08-16Sale10,000.0$42.85
DeSilva Nishan MVP, Corporate Development2013-06-28Purchase169.0$17.36
FOEHR MATTHEW WEVP and COO2013-06-28Purchase1,059.0$17.36
Berkman Charles SVP, Gen. Counsel & Secretary2013-06-28Purchase815.0$17.36
Berkman Charles SVP, Gen. Counsel & Secretary2013-05-10Sale4,000.0$26.66
BIOTECHNOLOGY VALUE FUND L POther2013-01-23Purchase39,600.0$19.78
BVF PARTNERS L P/ILTenPercentOwner2013-01-23Purchase39,600.0$19.78
BVF INC/ILTenPercentOwner2013-01-23Purchase39,600.0$19.78
BIOTECHNOLOGY VALUE FUND II LPOther2013-01-23Purchase39,600.0$19.78
BVF INVESTMENTS LLCOther2013-01-23Purchase39,600.0$19.78